These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1816068)

  • 1. Decreased free insulin levels during euglycemic hyperinsulinemic clamp in non-insulin dependent diabetics on insulin therapy.
    Babić D; Rocić B; Granić M; Skrabalo Z
    Horm Metab Res; 1991 Nov; 23(11):565-6. PubMed ID: 1816068
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of an early decline in baseline plasma glucose concentration after acute insulin elevation during euglycemic hyperinsulinemic clamp in patients with type 2 diabetes mellitus.
    Wasada T; Kuroki H; Arii H; Sato A; Katsumori K; Saito S; Iwamoto Y
    Endocr J; 2000 Jun; 47(3):309-16. PubMed ID: 11036875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin sensitivity in vivo: evaluation of non insulin dependent diabetes mellitus patients and healthy subjects by euglycemic hyperinsulinemic clamp].
    Calvillán M; Durruty P; López G; Rocha G
    Rev Med Chil; 1991 Oct; 119(10):1101-8. PubMed ID: 1845203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hyperinsulinemia is associated with increased circulating levels of adrenomedullin in patients with type 2 diabetes mellitus.
    Katsuki A; Sumida Y; Gabazza EC; Murashima S; Urakawa H; Morioka K; Kitagawa N; Tanaka T; Araki-Sasaki R; Hori Y; Nakatani K; Yano Y; Adachi Y
    Eur J Endocrinol; 2002 Jul; 147(1):71-5. PubMed ID: 12088922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of acute inhibitory effect of insulin on chylomicron production in type 2 diabetes.
    Nogueira JP; Maraninchi M; Béliard S; Padilla N; Duvillard L; Mancini J; Nicolay A; Xiao C; Vialettes B; Lewis GF; Valéro R
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):1039-44. PubMed ID: 22308041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men.
    Ferri C; Carlomagno A; Coassin S; Baldoncini R; Cassone Faldetta MR; Laurenti O; Properzi G; Santucci A; De Mattia G
    Diabetes Care; 1995 Feb; 18(2):226-33. PubMed ID: 7729302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of insulin sensitivity values using the hyperinsulinemic euglycemic clamp: 2 vs 3 hours.
    Karelis AD; Henry JF; Malita F; St-Pierre DH; Vigneault I; Poehlman ET; Rabasa-Lhoret R
    Diabetes Metab; 2004 Nov; 30(5):413-4. PubMed ID: 15671908
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible novel index determined by the glucose clamp test for selection of a suitable therapy for each type 2 diabetic patient.
    Gorogawa S; Kaneto H; Matsuhisa M; Ohtoshi K; Kawamori D; Hazama Y; Yoshiuchi K; Yamasaki Y
    Diabetes Res Clin Pract; 2005 Jul; 69(1):1-4. PubMed ID: 15955381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
    Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
    Cummings MH; Watts GF; Umpleby AM; Hennessy TR; Kelly JM; Jackson NC; Sönksen PH
    Diabetes; 1995 Sep; 44(9):1059-65. PubMed ID: 7657029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians.
    Nagi DK; Tracy R; Pratley R
    Metabolism; 1996 Oct; 45(10):1243-7. PubMed ID: 8843179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects.
    Fonseca VA; Mudaliar S; Schmidt B; Fink LM; Kern PA; Henry RR
    Metabolism; 1998 Jun; 47(6):686-9. PubMed ID: 9627367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The day-to-day variation in insulin sensitivity in non-insulin-dependent diabetes mellitus patients assessed by the hyperinsulinemic-euglycemic clamp method.
    Thomsen C; Storm H; Christiansen C; Rasmussen OW; Larsen MK; Hermansen K
    Metabolism; 1997 Apr; 46(4):374-6. PubMed ID: 9109838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of insulin sensitivity assessment indices with euglycemic-hyperinsulinemic clamp data after a dietary and exercise intervention in older adults.
    Hays NP; Starling RD; Sullivan DH; Fluckey JD; Coker RH; Evans WJ
    Metabolism; 2006 Apr; 55(4):525-32. PubMed ID: 16546484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperglycemia prevents the suppressive effect of hyperinsulinemia on plasma adiponectin levels in healthy humans.
    Blümer RM; van der Crabben SN; Stegenga ME; Tanck MW; Ackermans MT; Endert E; van der Poll T; Sauerwein HP
    Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E613-7. PubMed ID: 18577692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the [13C]glucose breath test to the hyperinsulinemic-euglycemic clamp when determining insulin resistance.
    Lewanczuk RZ; Paty BW; Toth EL
    Diabetes Care; 2004 Feb; 27(2):441-7. PubMed ID: 14747226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Different establishing conditions of hyperinsulinemic-euglycemic clamp technique among different groups].
    Yang G; Li CL; Tian H; Cheng SW; Li YJ; Cheng XL; Fang FS
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(34):2410-4. PubMed ID: 23158664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digitalis-like factor response to hyperinsulinemia accompanying a euglycemic hyperinsulinemic clamp or oral glucose tolerance test.
    Carroll JS; Seely EW; Tao QF; Graves SW
    Life Sci; 2001 Jul; 69(7):829-37. PubMed ID: 11487094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of fluorescence tracer in hyperinsulinemic-euglycemic clamp test in mice.
    Ye F; Tao R; Cong W; Tian J; Liu Q
    J Biochem Biophys Methods; 2008 Apr; 70(6):978-84. PubMed ID: 18355922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.